Curemark has a Late-Stage Autism program and lead candidates for ADHD, Schizophrenia, Parkinson’s and Addiction.
Novel Approaches to the Treatment of Neurological Diseases
Curemark Named To The Red Herring Top 100Curemark, a leading drug research and development company focused on the treatment of neurological and other diseases,
announced today that the company was named a Red Herring Top 100 North American award-winner.
Curemark Featured in Fast Company with Google & Purina (Nestle):
Great Companies Solve Problems That Matter
Consider Curemark, a biotech company founded by pediatric doctor Joan Fallon. She noticed many autistic children were low on a
certain kind of enzyme for processing protein.
Curemark Begins NDA Submission
for CM-AT Autism Treatment
Curemark LLC announced that it has begun the rolling submission of a New Drug Application (NDA) for CM-AT, the company's
autism treatment, with the U.S. Food and Drug Administration.
Our technology focuses on addressing exocrine pancreatic deficiencies to potentially improve symptoms of several neurologic diseases.